Stay updated on Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedRevision label on the page updated from v3.4.1 to v3.4.2, replacing the previous version.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision: v3.4.1 was added and revision: v3.4.0 was removed. This appears to be a backend/UI version update with no visible changes to the study details.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision metadata updated from v3.3.3 to v3.3.4. This appears to be a minor version update with no changes to the study content, eligibility criteria, or listed locations.SummaryDifference0.0%

- Check58 days agoChange DetectedLocations section updated: Colorado, Massachusetts, New York, North Dakota, Ohio, South Dakota, and Texas are listed; corresponding state location entries were removed. Revision tag updated from v3.3.2 to v3.3.3.SummaryDifference0.6%

- Check87 days agoChange DetectedThe Publications section wording was updated to state that publications are automatically filled in from PubMed and may not be about the study, replacing the previous phrasing. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check94 days agoChange DetectedThe government funding status notice banner was removed from the page. The study details and navigation remained unchanged.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.